For years drug companies have abandoned the search for new antibiotics, saying it isn't worth their while. Now some are getting back into the hunt.. After dismantling its antibiotics team in 1999, Switzerland's Roche Holding AG is recruiting a head of anti-infectives to rebuild its in-house expertise. Last year, Roche licensed an experimental new antibiotic from Polyphor Ltd., a biotechnology company, and is investing as much as $111 million in antibiotic-focused RQX Pharmaceuticals Inc.